We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SYF:NYSESynchrony Financial Analysis

Data as of 2026-03-10 - not real-time

$66.33

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Synchrony Financial (SYF) is trading at around $66.33, well below its 20‑day SMA of $70.6 and the 200‑day SMA of $72.8, indicating a price deficit. The RSI of 34.6 places the stock in oversold territory, while the MACD remains bearish, suggesting short‑term downside pressure. Support is identified near $63.74 and resistance around $75.04, framing the current price near the lower bound of that range. Volatility is elevated at roughly 39% over the past 30 days and beta exceeds 1.5, highlighting heightened market sensitivity. Despite the technical headwinds, a recent Baird upgrade to Outperform and an average analyst price target of $93.5 imply an upside of about 30% from recent levels. The renewal of the financing partnership with Polaris adds a tangible growth catalyst in the specialty vehicle segment.
On the fundamentals side, SYF posts a trailing PE of ~7x versus an industry average of ~17x, a strong operating margin of 48.5%, and a solid dividend yield of 1.79% with a modest 12% payout. Cash on hand ($14.97 bn) essentially matches total debt, resulting in a net‑cash position that underpins dividend sustainability. The DCF fair‑value estimate of $327.9 suggests the market is severely discounting future earnings, reinforcing an undervalued classification. The company’s exposure is primarily domestic, limiting geographic and currency risk, while its credit‑card business carries moderate regulatory and sector risk. Taken together, the blend of deep valuation discounts, improving earnings outlook, and a stable dividend makes SYF an attractive candidate for investors with a medium‑ to long‑term horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering near technical support at $63.74
  • Bearish MACD histogram indicating short‑term downside
  • RSI in oversold zone suggesting possible rebound

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst upgrade to Outperform with ~30% upside target
  • Significant valuation gap (PE ~7x vs industry ~17x)
  • Renewed Polaris financing partnership expanding revenue streams

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • DCF fair‑value estimate far above current price
  • Sustainable dividend supported by net‑cash balance
  • Strong operating margins and low payout ratio

Key Metrics & Analysis

Financial Health

Revenue Growth5.00%
Profit Margin36.41%
P/E Ratio7.1
ROE21.30%
ROA2.98%
P/B Ratio1.5
Op. Cash Flow$9.9B
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI34.6
Support$63.74
Resistance$75.04
MA 20$70.57
MA 50$75.77
MA 200$72.80
MACDBearish
VolumeDecreasing
Fear & Greed Index80.59

Valuation

Fair Value$327.87
Target Price$90.00
Upside/Downside35.69%
GradeUndervalued
TypeValue
Dividend Yield1.79%

Risk Assessment

Beta1.57
Volatility38.93%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.